Premier Alternatives

Cofactor Genomics

Saint Louis, MO · Privately Held (backing)

Developer of a precision diagnostic assay designed to predict immune responses in oncology. Cofactor Genomics is based in Saint Louis, MO. It was valued at $41.9 million at its later-stage round in Dec 2021, the last priced event on record. It has raised $28.7 million across 2 recorded rounds; the latest was a $6.9 million early-stage round in Dec 2021.

PMV mark · valuation
$41.9M
Oct 2026
Priced at
its later-stage round
Dec 2021
Total raised
$28.7M
Last round
Early Stage VC
Dec 2021

Cofactor Genomics key facts

as of Oct 2026
  • Developer of a precision diagnostic assay designed to predict immune responses in oncology.
  • Cofactor Genomics is valued at approximately $41.9M as of Oct 2026, set at its later-stage round, Dec 2021; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $28.7M across 2 recorded rounds; the latest was Early Stage VC ($6.9M) in Dec 2021.
  • Notable investors include Y Combinator, Menlo Ventures, DCVC, AME Cloud Ventures, SVB Financial Group (Dallas) — 30 tracked in total.
  • Cofactor Genomics has filed 2 Form Ds with the SEC since 2017, most recently Dec 2021 ($6.9M sold to 9 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$41.9M

Valued at $41.9M at its later-stage round, Dec 2021. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Cofactor Genomics with a free account
  • ·The complete investor list: 30 names
  • ·Watch Cofactor Genomics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Cofactor Genomics funding rounds

2 rounds
Dec 2021Early Stage VC$6.9MSEC filing▮
Jun 2017Early Stage VC$10.7MSEC filing▮
Full funding history →

Cofactor Genomics valuation

Cofactor Genomics was valued at $41.9 million at its later-stage round in Dec 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Cofactor Genomics raised?

Cofactor Genomics has raised $28.7 million in total; 2 of its rounds are on record. The largest on record was a $6.9 million early-stage round in Dec 2021.

Cofactor Genomics has filed 2 Form Ds with the SEC since 2017, most recently in Dec 2021 ($6.9 million sold to 9 investors).

Cofactor Genomics investors

30 investors are on record for Cofactor Genomics, including Y Combinator, Menlo Ventures, DCVC and AME Cloud Ventures. By type, the record holds 12 venture capital firms and 1 fund of funds. The early-stage round in Dec 2021 drew 9 investors.

About Cofactor Genomics

Developer of a precision diagnostic assay designed to predict immune responses in oncology. The company offers a machine learning-driven platform that analyzes ribonucleic acid (RNA) sequencing data, enabling healthcare providers to better identify patients likely to benefit from immunotherapy.

Sector
Healthcare
HQ
Saint Louis, MO, United States
Employees
11
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.